1 Study Coverage
    1.1 Thrombin (Human) Product Introduction
    1.2 Market by Type
        1.2.1 Global Thrombin (Human) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 500IU/Vial
        1.2.3 1000IU/Vial
        1.2.4 2500IU/Vial
    1.3 Market by Application
        1.3.1 Global Thrombin (Human) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Biotechnology
        1.3.3 Medicine
        1.3.4 Microbiology
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Thrombin (Human) Sales Estimates and Forecasts 2017-2028
    2.2 Global Thrombin (Human) Revenue Estimates and Forecasts 2017-2028
    2.3 Global Thrombin (Human) Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Thrombin (Human) Sales by Region
        2.4.1 Global Thrombin (Human) Sales by Region (2017-2022)
        2.4.2 Global Sales Thrombin (Human) by Region (2023-2028)
    2.5 Global Thrombin (Human) Revenue by Region
        2.5.1 Global Thrombin (Human) Revenue by Region (2017-2022)
        2.5.2 Global Thrombin (Human) Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Thrombin (Human) Sales by Manufacturers
        3.1.1 Global Top Thrombin (Human) Manufacturers by Sales (2017-2022)
        3.1.2 Global Thrombin (Human) Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Thrombin (Human) in 2021
    3.2 Global Thrombin (Human) Revenue by Manufacturers
        3.2.1 Global Thrombin (Human) Revenue by Manufacturers (2017-2022)
        3.2.2 Global Thrombin (Human) Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Thrombin (Human) Revenue in 2021
    3.3 Global Thrombin (Human) Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Thrombin (Human) Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Thrombin (Human) Sales by Type
        4.1.1 Global Thrombin (Human) Historical Sales by Type (2017-2022)
        4.1.2 Global Thrombin (Human) Forecasted Sales by Type (2023-2028)
        4.1.3 Global Thrombin (Human) Sales Market Share by Type (2017-2028)
    4.2 Global Thrombin (Human) Revenue by Type
        4.2.1 Global Thrombin (Human) Historical Revenue by Type (2017-2022)
        4.2.2 Global Thrombin (Human) Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Thrombin (Human) Revenue Market Share by Type (2017-2028)
    4.3 Global Thrombin (Human) Price by Type
        4.3.1 Global Thrombin (Human) Price by Type (2017-2022)
        4.3.2 Global Thrombin (Human) Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Thrombin (Human) Sales by Application
        5.1.1 Global Thrombin (Human) Historical Sales by Application (2017-2022)
        5.1.2 Global Thrombin (Human) Forecasted Sales by Application (2023-2028)
        5.1.3 Global Thrombin (Human) Sales Market Share by Application (2017-2028)
    5.2 Global Thrombin (Human) Revenue by Application
        5.2.1 Global Thrombin (Human) Historical Revenue by Application (2017-2022)
        5.2.2 Global Thrombin (Human) Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Thrombin (Human) Revenue Market Share by Application (2017-2028)
    5.3 Global Thrombin (Human) Price by Application
        5.3.1 Global Thrombin (Human) Price by Application (2017-2022)
        5.3.2 Global Thrombin (Human) Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Thrombin (Human) Market Size by Type
        6.1.1 North America Thrombin (Human) Sales by Type (2017-2028)
        6.1.2 North America Thrombin (Human) Revenue by Type (2017-2028)
    6.2 North America Thrombin (Human) Market Size by Application
        6.2.1 North America Thrombin (Human) Sales by Application (2017-2028)
        6.2.2 North America Thrombin (Human) Revenue by Application (2017-2028)
    6.3 North America Thrombin (Human) Market Size by Country
        6.3.1 North America Thrombin (Human) Sales by Country (2017-2028)
        6.3.2 North America Thrombin (Human) Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Thrombin (Human) Market Size by Type
        7.1.1 Europe Thrombin (Human) Sales by Type (2017-2028)
        7.1.2 Europe Thrombin (Human) Revenue by Type (2017-2028)
    7.2 Europe Thrombin (Human) Market Size by Application
        7.2.1 Europe Thrombin (Human) Sales by Application (2017-2028)
        7.2.2 Europe Thrombin (Human) Revenue by Application (2017-2028)
    7.3 Europe Thrombin (Human) Market Size by Country
        7.3.1 Europe Thrombin (Human) Sales by Country (2017-2028)
        7.3.2 Europe Thrombin (Human) Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Thrombin (Human) Market Size by Type
        8.1.1 Asia Pacific Thrombin (Human) Sales by Type (2017-2028)
        8.1.2 Asia Pacific Thrombin (Human) Revenue by Type (2017-2028)
    8.2 Asia Pacific Thrombin (Human) Market Size by Application
        8.2.1 Asia Pacific Thrombin (Human) Sales by Application (2017-2028)
        8.2.2 Asia Pacific Thrombin (Human) Revenue by Application (2017-2028)
    8.3 Asia Pacific Thrombin (Human) Market Size by Region
        8.3.1 Asia Pacific Thrombin (Human) Sales by Region (2017-2028)
        8.3.2 Asia Pacific Thrombin (Human) Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Thrombin (Human) Market Size by Type
        9.1.1 Latin America Thrombin (Human) Sales by Type (2017-2028)
        9.1.2 Latin America Thrombin (Human) Revenue by Type (2017-2028)
    9.2 Latin America Thrombin (Human) Market Size by Application
        9.2.1 Latin America Thrombin (Human) Sales by Application (2017-2028)
        9.2.2 Latin America Thrombin (Human) Revenue by Application (2017-2028)
    9.3 Latin America Thrombin (Human) Market Size by Country
        9.3.1 Latin America Thrombin (Human) Sales by Country (2017-2028)
        9.3.2 Latin America Thrombin (Human) Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Thrombin (Human) Market Size by Type
        10.1.1 Middle East and Africa Thrombin (Human) Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Thrombin (Human) Revenue by Type (2017-2028)
    10.2 Middle East and Africa Thrombin (Human) Market Size by Application
        10.2.1 Middle East and Africa Thrombin (Human) Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Thrombin (Human) Revenue by Application (2017-2028)
    10.3 Middle East and Africa Thrombin (Human) Market Size by Country
        10.3.1 Middle East and Africa Thrombin (Human) Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Thrombin (Human) Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Baxter
        11.1.1 Baxter Corporation Information
        11.1.2 Baxter Overview
        11.1.3 Baxter Thrombin (Human) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Baxter Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Baxter Recent Developments
    11.2 AMRESCO Inc
        11.2.1 AMRESCO Inc Corporation Information
        11.2.2 AMRESCO Inc Overview
        11.2.3 AMRESCO Inc Thrombin (Human) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 AMRESCO Inc Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 AMRESCO Inc Recent Developments
    11.3 BD Biosciences
        11.3.1 BD Biosciences Corporation Information
        11.3.2 BD Biosciences Overview
        11.3.3 BD Biosciences Thrombin (Human) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 BD Biosciences Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 BD Biosciences Recent Developments
    11.4 Life Technologies Corporation
        11.4.1 Life Technologies Corporation Corporation Information
        11.4.2 Life Technologies Corporation Overview
        11.4.3 Life Technologies Corporation Thrombin (Human) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Life Technologies Corporation Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Life Technologies Corporation Recent Developments
    11.5 PromoCell GmbH
        11.5.1 PromoCell GmbH Corporation Information
        11.5.2 PromoCell GmbH Overview
        11.5.3 PromoCell GmbH Thrombin (Human) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 PromoCell GmbH Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 PromoCell GmbH Recent Developments
    11.6 Sigma-Aldrich Corporation
        11.6.1 Sigma-Aldrich Corporation Corporation Information
        11.6.2 Sigma-Aldrich Corporation Overview
        11.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Sigma-Aldrich Corporation Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Sigma-Aldrich Corporation Recent Developments
    11.7 Vitrolife AB
        11.7.1 Vitrolife AB Corporation Information
        11.7.2 Vitrolife AB Overview
        11.7.3 Vitrolife AB Thrombin (Human) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Vitrolife AB Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Vitrolife AB Recent Developments
    11.8 CSL
        11.8.1 CSL Corporation Information
        11.8.2 CSL Overview
        11.8.3 CSL Thrombin (Human) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 CSL Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 CSL Recent Developments
    11.9 Bayer
        11.9.1 Bayer Corporation Information
        11.9.2 Bayer Overview
        11.9.3 Bayer Thrombin (Human) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Bayer Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Bayer Recent Developments
    11.10 Grifols
        11.10.1 Grifols Corporation Information
        11.10.2 Grifols Overview
        11.10.3 Grifols Thrombin (Human) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Grifols Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Grifols Recent Developments
    11.11 Octapharma
        11.11.1 Octapharma Corporation Information
        11.11.2 Octapharma Overview
        11.11.3 Octapharma Thrombin (Human) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Octapharma Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Octapharma Recent Developments
    11.12 Shanghai RAAS
        11.12.1 Shanghai RAAS Corporation Information
        11.12.2 Shanghai RAAS Overview
        11.12.3 Shanghai RAAS Thrombin (Human) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Shanghai RAAS Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Shanghai RAAS Recent Developments
    11.13 Hualan Biological
        11.13.1 Hualan Biological Corporation Information
        11.13.2 Hualan Biological Overview
        11.13.3 Hualan Biological Thrombin (Human) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Hualan Biological Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Hualan Biological Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Thrombin (Human) Industry Chain Analysis
    12.2 Thrombin (Human) Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Thrombin (Human) Production Mode & Process
    12.4 Thrombin (Human) Sales and Marketing
        12.4.1 Thrombin (Human) Sales Channels
        12.4.2 Thrombin (Human) Distributors
    12.5 Thrombin (Human) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Thrombin (Human) Industry Trends
    13.2 Thrombin (Human) Market Drivers
    13.3 Thrombin (Human) Market Challenges
    13.4 Thrombin (Human) Market Restraints
14 Key Findings in The Global Thrombin (Human) Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Thrombin (Human) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 500IU/Vial
    Table 3. Major Manufacturers of 1000IU/Vial
    Table 4. Major Manufacturers of 2500IU/Vial
    Table 5. Global Thrombin (Human) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Thrombin (Human) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Thrombin (Human) Sales by Region (2017-2022) & (K Units)
    Table 8. Global Thrombin (Human) Sales Market Share by Region (2017-2022)
    Table 9. Global Thrombin (Human) Sales by Region (2023-2028) & (K Units)
    Table 10. Global Thrombin (Human) Sales Market Share by Region (2023-2028)
    Table 11. Global Thrombin (Human) Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Thrombin (Human) Revenue Market Share by Region (2017-2022)
    Table 13. Global Thrombin (Human) Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Thrombin (Human) Revenue Market Share by Region (2023-2028)
    Table 15. Global Thrombin (Human) Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Thrombin (Human) Sales Share by Manufacturers (2017-2022)
    Table 17. Global Thrombin (Human) Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Thrombin (Human) Revenue Share by Manufacturers (2017-2022)
    Table 19. Thrombin (Human) Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Thrombin (Human) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Thrombin (Human) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombin (Human) as of 2021)
    Table 22. Thrombin (Human) Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Thrombin (Human) Product Offered
    Table 24. Date of Manufacturers Enter into Thrombin (Human) Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Thrombin (Human) Sales by Type (2017-2022) & (K Units)
    Table 27. Global Thrombin (Human) Sales by Type (2023-2028) & (K Units)
    Table 28. Global Thrombin (Human) Sales Share by Type (2017-2022)
    Table 29. Global Thrombin (Human) Sales Share by Type (2023-2028)
    Table 30. Global Thrombin (Human) Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Thrombin (Human) Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Thrombin (Human) Revenue Share by Type (2017-2022)
    Table 33. Global Thrombin (Human) Revenue Share by Type (2023-2028)
    Table 34. Thrombin (Human) Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Thrombin (Human) Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Thrombin (Human) Sales by Application (2017-2022) & (K Units)
    Table 37. Global Thrombin (Human) Sales by Application (2023-2028) & (K Units)
    Table 38. Global Thrombin (Human) Sales Share by Application (2017-2022)
    Table 39. Global Thrombin (Human) Sales Share by Application (2023-2028)
    Table 40. Global Thrombin (Human) Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Thrombin (Human) Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Thrombin (Human) Revenue Share by Application (2017-2022)
    Table 43. Global Thrombin (Human) Revenue Share by Application (2023-2028)
    Table 44. Thrombin (Human) Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Thrombin (Human) Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Thrombin (Human) Sales by Type (2017-2022) & (K Units)
    Table 47. North America Thrombin (Human) Sales by Type (2023-2028) & (K Units)
    Table 48. North America Thrombin (Human) Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Thrombin (Human) Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Thrombin (Human) Sales by Application (2017-2022) & (K Units)
    Table 51. North America Thrombin (Human) Sales by Application (2023-2028) & (K Units)
    Table 52. North America Thrombin (Human) Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Thrombin (Human) Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Thrombin (Human) Sales by Country (2017-2022) & (K Units)
    Table 55. North America Thrombin (Human) Sales by Country (2023-2028) & (K Units)
    Table 56. North America Thrombin (Human) Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Thrombin (Human) Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Thrombin (Human) Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Thrombin (Human) Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Thrombin (Human) Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Thrombin (Human) Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Thrombin (Human) Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Thrombin (Human) Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Thrombin (Human) Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Thrombin (Human) Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Thrombin (Human) Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Thrombin (Human) Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Thrombin (Human) Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Thrombin (Human) Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Thrombin (Human) Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Thrombin (Human) Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Thrombin (Human) Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Thrombin (Human) Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Thrombin (Human) Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Thrombin (Human) Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Thrombin (Human) Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Thrombin (Human) Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Thrombin (Human) Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Thrombin (Human) Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Thrombin (Human) Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Thrombin (Human) Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Thrombin (Human) Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Thrombin (Human) Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Thrombin (Human) Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Thrombin (Human) Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Thrombin (Human) Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Thrombin (Human) Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Thrombin (Human) Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Thrombin (Human) Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Thrombin (Human) Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Thrombin (Human) Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Thrombin (Human) Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Thrombin (Human) Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Thrombin (Human) Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Thrombin (Human) Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Thrombin (Human) Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Thrombin (Human) Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Thrombin (Human) Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Thrombin (Human) Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Thrombin (Human) Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Thrombin (Human) Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Thrombin (Human) Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Thrombin (Human) Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Thrombin (Human) Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Thrombin (Human) Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Baxter Corporation Information
    Table 107. Baxter Description and Major Businesses
    Table 108. Baxter Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Baxter Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Baxter Recent Developments
    Table 111. AMRESCO Inc Corporation Information
    Table 112. AMRESCO Inc Description and Major Businesses
    Table 113. AMRESCO Inc Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. AMRESCO Inc Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. AMRESCO Inc Recent Developments
    Table 116. BD Biosciences Corporation Information
    Table 117. BD Biosciences Description and Major Businesses
    Table 118. BD Biosciences Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. BD Biosciences Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. BD Biosciences Recent Developments
    Table 121. Life Technologies Corporation Corporation Information
    Table 122. Life Technologies Corporation Description and Major Businesses
    Table 123. Life Technologies Corporation Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Life Technologies Corporation Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Life Technologies Corporation Recent Developments
    Table 126. PromoCell GmbH Corporation Information
    Table 127. PromoCell GmbH Description and Major Businesses
    Table 128. PromoCell GmbH Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. PromoCell GmbH Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. PromoCell GmbH Recent Developments
    Table 131. Sigma-Aldrich Corporation Corporation Information
    Table 132. Sigma-Aldrich Corporation Description and Major Businesses
    Table 133. Sigma-Aldrich Corporation Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Sigma-Aldrich Corporation Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Sigma-Aldrich Corporation Recent Developments
    Table 136. Vitrolife AB Corporation Information
    Table 137. Vitrolife AB Description and Major Businesses
    Table 138. Vitrolife AB Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Vitrolife AB Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Vitrolife AB Recent Developments
    Table 141. CSL Corporation Information
    Table 142. CSL Description and Major Businesses
    Table 143. CSL Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. CSL Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. CSL Recent Developments
    Table 146. Bayer Corporation Information
    Table 147. Bayer Description and Major Businesses
    Table 148. Bayer Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Bayer Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Bayer Recent Developments
    Table 151. Grifols Corporation Information
    Table 152. Grifols Description and Major Businesses
    Table 153. Grifols Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Grifols Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Grifols Recent Developments
    Table 156. Octapharma Corporation Information
    Table 157. Octapharma Description and Major Businesses
    Table 158. Octapharma Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 159. Octapharma Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Octapharma Recent Developments
    Table 161. Shanghai RAAS Corporation Information
    Table 162. Shanghai RAAS Description and Major Businesses
    Table 163. Shanghai RAAS Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 164. Shanghai RAAS Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Shanghai RAAS Recent Developments
    Table 166. Hualan Biological Corporation Information
    Table 167. Hualan Biological Description and Major Businesses
    Table 168. Hualan Biological Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 169. Hualan Biological Thrombin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. Hualan Biological Recent Developments
    Table 171. Key Raw Materials Lists
    Table 172. Raw Materials Key Suppliers Lists
    Table 173. Thrombin (Human) Distributors List
    Table 174. Thrombin (Human) Customers List
    Table 175. Thrombin (Human) Market Trends
    Table 176. Thrombin (Human) Market Drivers
    Table 177. Thrombin (Human) Market Challenges
    Table 178. Thrombin (Human) Market Restraints
    Table 179. Research Programs/Design for This Report
    Table 180. Key Data Information from Secondary Sources
    Table 181. Key Data Information from Primary Sources
List of Figures
    Figure 1. Thrombin (Human) Product Picture
    Figure 3. Global Thrombin (Human) Market Share by Type in 2021 & 2028
    Figure 3. 500IU/Vial Product Picture
    Figure 4. 1000IU/Vial Product Picture
    Figure 5. 2500IU/Vial Product Picture
    Figure 6. Global Thrombin (Human) Market Share by Application in 2021 & 2028
    Figure 7. Biotechnology
    Figure 8. Medicine
    Figure 9. Microbiology
    Figure 10. Others
    Figure 11. Thrombin (Human) Report Years Considered
    Figure 12. Global Thrombin (Human) Sales 2017-2028 (K Units)
    Figure 13. Global Thrombin (Human) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Thrombin (Human) Revenue 2017-2028 (US$ Million)
    Figure 15. Global Thrombin (Human) Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Thrombin (Human) Sales Market Share by Region (2017-2022)
    Figure 17. Global Thrombin (Human) Sales Market Share by Region (2023-2028)
    Figure 18. North America Thrombin (Human) Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Thrombin (Human) Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Thrombin (Human) Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Thrombin (Human) Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Thrombin (Human) Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Thrombin (Human) Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Thrombin (Human) Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Thrombin (Human) Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Thrombin (Human) Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Thrombin (Human) Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Thrombin (Human) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Thrombin (Human) in the World: Market Share by Thrombin (Human) Revenue in 2021
    Figure 30. Global Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Thrombin (Human) Sales Market Share by Type (2017-2028)
    Figure 32. Global Thrombin (Human) Revenue Market Share by Type (2017-2028)
    Figure 33. Global Thrombin (Human) Sales Market Share by Application (2017-2028)
    Figure 34. Global Thrombin (Human) Revenue Market Share by Application (2017-2028)
    Figure 35. North America Thrombin (Human) Sales Market Share by Type (2017-2028)
    Figure 36. North America Thrombin (Human) Revenue Market Share by Type (2017-2028)
    Figure 37. North America Thrombin (Human) Sales Market Share by Application (2017-2028)
    Figure 38. North America Thrombin (Human) Revenue Market Share by Application (2017-2028)
    Figure 39. North America Thrombin (Human) Sales Share by Country (2017-2028)
    Figure 40. North America Thrombin (Human) Revenue Share by Country (2017-2028)
    Figure 41. U.S. Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Thrombin (Human) Sales Market Share by Type (2017-2028)
    Figure 44. Europe Thrombin (Human) Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Thrombin (Human) Sales Market Share by Application (2017-2028)
    Figure 46. Europe Thrombin (Human) Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Thrombin (Human) Sales Share by Country (2017-2028)
    Figure 48. Europe Thrombin (Human) Revenue Share by Country (2017-2028)
    Figure 49. Germany Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 50. France Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Thrombin (Human) Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Thrombin (Human) Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Thrombin (Human) Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Thrombin (Human) Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Thrombin (Human) Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Thrombin (Human) Revenue Share by Region (2017-2028)
    Figure 60. China Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 63. India Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Thrombin (Human) Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Thrombin (Human) Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Thrombin (Human) Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Thrombin (Human) Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Thrombin (Human) Sales Share by Country (2017-2028)
    Figure 75. Latin America Thrombin (Human) Revenue Share by Country (2017-2028)
    Figure 76. Mexico Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Thrombin (Human) Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Thrombin (Human) Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Thrombin (Human) Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Thrombin (Human) Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Thrombin (Human) Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Thrombin (Human) Revenue Share by Country (2017-2028)
    Figure 85. Turkey Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Thrombin (Human) Revenue (2017-2028) & (US$ Million)
    Figure 88. Thrombin (Human) Value Chain
    Figure 89. Thrombin (Human) Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed